title: Seeking the value of pharmacogenetics in cardiovascular care.
abstract: Two presentations at the 2006 Scientific Sessions of the American Heart Association debated the effect of genetics on such drugs as warfarin and isosorbide dinitrate/hydralazine (BiDil). The speakers emphasized that the pharmacogenetics field is advancing quickly, but is not yet mature in terms of therapeutic options.
authors: John
authors: J
authors: Otrompke